Screening for Circulating Tumor Cells with a Microfluidics Device
May 30, 2023 | Terry Sharrer
“Researchers from the University of Technology Sydney have developed a new device that can detect and analyse cancer cells from blood samples, enabling doctors to avoid invasive biopsy surgeries, and to monitor treatment progress. . . . . The Static Droplet Microfluidic device is able to rapidly detect circulating tumour cells that have broken away from a primary tumour and entered the bloodstream. The device uses a unique metabolic signature of cancer to differentiate tumour cells from normal blood cells. The study, Rapid metabolomic screening of cancer cells via high-throughput static droplet microfluidics, has just been published in the peer-reviewed scientific journal, Biosensors and Bioelectronics.” MORE
Image Credit: University of Technology Sydney